Refine Your Results

Click below to filter your search results

"Committee Opinion"Undo

Search Results

Return to List
Results 1–20 of 217
Title Date
1.

Management of Pregnant Women With Presumptive Exposure to Listeria monocytogenes

Number 614

ABSTRACT: Listeriosis is predominantly a foodborne illness, with sporadic and outbreak-related cases tied to consumption of food contaminated with listeria (Listeria monocytogenes). The incidence of listeriosis associated with pregnancy is approximately 13 times higher than in the general populati...

December 2014

PDF Format
2.

Increasing Access to Abortion

Number 613

(Replaces No. 424, January 2009)

ABSTRACT: Safe, legal abortion is a necessary component of women’s health care. The American College of Obstetricians and Gynecologists supports the availability of high-quality reproductive health services for all women and is committed to improving access to abortion. Access to abortion is threa...

November 2014

PDF Format
3.

Abortion Training and Education

Number 612

(Replaces No. 424, January 2009)

ABSTRACT: Access to safe abortion hinges upon the availability of trained abortion providers. The American College of Obstetricians and Gynecologists supports education for students in health care fields as well as clinical training for residents and advanced practice clinicians in abortion care i...

November 2014

PDF Format
4.

Method for Estimating Due Date

Number 611

(See also Committee Opinion No. 579)

ABSTRACT: Accurate dating of pregnancy is important to improve outcomes and is a research and public health imperative. As soon as data from the last menstrual period, the first accurate ultrasound examination, or both are obtained, the gestational age and the estimated due date should be determin...

October 2014

PDF Format
5.

Chronic Antithrombotic Therapy and Gynecologic Surgery

Number 610

ABSTRACT: Surgery can present a management dilemma for gynecologists whose patients receive chronic antithrombotic therapy because the risk of hemorrhagic complications must be balanced against the risk of thromboembolic complications. Interruption of antithrombotic therapy to reduce perioperative...

October 2014

PDF Format
6.

Colorectal Cancer Screening Strategies

Number 609

ABSTRACT: Each year, more than 24,000 women die from colorectal cancer, which makes it the third leading cause of cancer death in women after lung cancer and breast cancer. However, screening tests are underused for many segments of the population and are ordered in a manner inconsistent with guid...

October 2014

PDF Format
7.

Influenza Vaccination During Pregnancy

Number 608

(Replaces No. 468, October 2010)

ABSTRACT: The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend that all adults receive an annual influenza vaccine. Influenza vaccination is an essential element of preconception, prenata...

September 2014

PDF Format
8.

Gynecologic Concerns in Children and Adolescents With Cancer

Number 607

ABSTRACT: Advancements in radiation therapy, chemotherapy, surgery, and multimodal treatment have dramatically improved childhood cancer survival. However, cancer and its treatment may have immediate or delayed adverse effects on reproductive health. Gynecologists should be prepared to manage gyne...

August 2014

PDF Format
9.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Number 606

ABSTRACT: Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding, and gynecologists may be consulted either before the initiation of cancer treatment to request strategies for menstrual suppression or during an episode of severe heavy bleeding to stop the bleeding eme...

August 2014

PDF Format
10.

Primary Ovarian Insufficiency in Adolescents and Young Women

Number 605

ABSTRACT: Primary ovarian insufficiency is the depletion or dysfunction of ovarian follicles with cessation of menses before age 40 years. There is no consensus on criteria to identify primary ovarian insufficiency in adolescents, and delay in diagnosis is common. Health care providers who make th...

July 2014

PDF Format
11.

OnabotulinumtoxinA and the Bladder

Number 604

ABSTRACT: In January 2013, the U.S. Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatment option for women. Symptoms of overactive bladder have been shown to significantly improve after ...

June 2014

PDF Format
12.

Evaluation of Uncomplicated Stress Urinary Incontinence in Women Before Surgical Treatment

Number 603

ABSTRACT: Stress urinary incontinence (SUI) is a condition of involuntary loss of urine on effort, physical exertion, sneezing, or coughing that is often bothersome to the patient and frequently affects quality of life. When women are evaluated for SUI, counseling about treatment should begin with...

June 2014

PDF Format
13.

Depot Medroxyprogesterone Acetate and Bone Effects

Number 602

(Replaces Committee Opinion Number 415, September 2008)

ABSTRACT: Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive that affords privacy and has a convenient dose schedule of four times per year, making it appealing to many users, especially adolescents. Although the use of DMPA is associated with loss of bone mine...

June 2014

PDF Format
14.

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT: Tamoxifen, a nonsteroidal antiestrogen agent, is widely used as adjunctive therapy for women with breast cancer, and it has been approved by the U.S. Food and Drug Administration for adjuvant treatment of breast cancer, treatment of metastatic breast cancer, and reduction in breast cance...

June 2014

PDF Format
15.

Ethical Issues in the Care of the Obese Woman

Number 600

ABSTRACT: Rates of obesity in the United States have increased rapidly over the past several decades, and physicians should be prepared to care for obese patients in a nonjudgmental manner, being cognizant of the medical, social, and ethical implications of obesity. It is the responsibility of the...

June 2014

PDF Format
16.

Adolescent Confidentiality and Electronic Health Records

Number 599

Abstract: Confidentiality concerns are heightened during adolescence, and these concerns can be a critical barrier to adolescents in receiving appropriate health care. Health care providers caring for minors should be aware of federal and state laws that affect confidentiality. State statutes on t...

May 2014

PDF Format
17.

The Initial Reproductive Health Visit

Number 598

(Replaces Committee Opinion Number 460, July 2010)

Abstract: The initial visit for screening and the provision of reproductive preventive health care services and guidance should take place between the ages of 13 years and 15 years. The initial reproductive health visit provides an excellent opportunity for the obstetrician–gynecologist to start a...

May 2014

PDF Format
18.

Labor Induction or Augmentation and Autism

Number 597

Abstract: Functional oxytocin deficiency and a faulty oxytocin signaling pathway have been observed in conjunction with autism spectrum disorder (ASD). Because exogenous synthetic oxytocin commonly is administered for labor induction and augmentation, some have hypothesized that synthetic oxytocin...

May 2014

PDF Format
19.

Routine Human Immunodeficiency Virus Screening

Number 596

(Replaces Committee Opinion Number 411, August 2008)

Abstract: Early diagnosis and treatment of human immunodeficiency virus (HIV) can improve survival and reduce morbidity. The Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists recommend that females aged 13–64 years be tested at least once in the...

May 2014

PDF Format
20.

Preexposure Prophylaxis for the Prevention of Human Immunodeficiency Virus

Number 595

Abstract: Preexposure prophylaxis is defined as the administration of antiretroviral medications to individuals who are not infected with human immunodeficiency virus (HIV) and are at the highest risk of acquiring HIV infection. In combination with other proven HIV-prevention methods, preexposure ...

May 2014

PDF Format